Yifang Bao1,2, Yan Chen3, Sirong Piao1,2, Bin Hu1,2, Liqin Yang1,2, Haiqing Li1,2, Daoying Geng4,5, Yuxin Li6,7. 1. Department of Radiology, Huashan Hospital, Fudan University, No. 12 Middle Wulumuqi Road, Jingan District, Shanghai, 200040, China. 2. Institute of Functional and Molecular Medical Imaging, Fudan University, Shanghai, 200040, China. 3. Department of Neurology, Huashan Hospital, Fudan University, Shanghai, 200040, China. 4. Department of Radiology, Huashan Hospital, Fudan University, No. 12 Middle Wulumuqi Road, Jingan District, Shanghai, 200040, China. gengdy@163.com. 5. Institute of Functional and Molecular Medical Imaging, Fudan University, Shanghai, 200040, China. gengdy@163.com. 6. Department of Radiology, Huashan Hospital, Fudan University, No. 12 Middle Wulumuqi Road, Jingan District, Shanghai, 200040, China. liyuxin@fudan.edu.cn. 7. Institute of Functional and Molecular Medical Imaging, Fudan University, Shanghai, 200040, China. liyuxin@fudan.edu.cn.
Abstract
OBJECTIVES: To explore whether the combined analysis of motor and bulbar region of M1 on susceptibility-weighted imaging (SWI) can be a valid biomarker for amyotrophic lateral sclerosis (ALS). METHODS: Thirty-two non-demented ALS patients and 35 age- and gender-matched healthy controls (HC) were retrospectively recruited. SWI and 3D-T1-MPRAGE images were obtained from all individuals using a 3.0-T MRI scan. The bilateral posterior band of M1 was manually delineated by three neuroradiologists on phase images and subdivided into the motor and bulbar regions. We compared the phase values in two groups and performed a stratification analysis (ALSFRS-R score, duration, disease progression rate, and onset). Receiver operating characteristic (ROC) curves were also constructed. RESULTS: ALS group showed significantly increased phase values in M1 and the two subregions than the HC group, on the all and elderly level (p < 0.001, respectively). On all-age level comparison, negative correlations were found between phase values of M1 and clinical score and duration (p < 0.05, respectively). Similar associations were found in the motor region (p < 0.05, respectively). On both the total (p < 0.01) and elderly (p < 0.05) levels, there were positive relationships between disease progression rate and M1 phase values. In comparing ROC curves, the entire M1 showed the best diagnostic performance. CONCLUSIONS: Combining motor and bulbar analyses as an integral M1 region on SWI can improve ALS diagnosis performance, especially in the elderly. The phase value could be a valuable biomarker for ALS evaluation. KEY POINTS: • Integrated analysis of the motor and bulbar as an entire M1 region on SWI can improve the diagnosis performance in ALS. • Quantitative analysis of iron deposition by SWI measurement helps the clinical evaluation, especially for the elderly patients. • Phase value, when combined with the disease progression rate, could be a valuable biomarker for ALS.
OBJECTIVES: To explore whether the combined analysis of motor and bulbar region of M1 on susceptibility-weighted imaging (SWI) can be a valid biomarker for amyotrophic lateral sclerosis (ALS). METHODS: Thirty-two non-demented ALS patients and 35 age- and gender-matched healthy controls (HC) were retrospectively recruited. SWI and 3D-T1-MPRAGE images were obtained from all individuals using a 3.0-T MRI scan. The bilateral posterior band of M1 was manually delineated by three neuroradiologists on phase images and subdivided into the motor and bulbar regions. We compared the phase values in two groups and performed a stratification analysis (ALSFRS-R score, duration, disease progression rate, and onset). Receiver operating characteristic (ROC) curves were also constructed. RESULTS: ALS group showed significantly increased phase values in M1 and the two subregions than the HC group, on the all and elderly level (p < 0.001, respectively). On all-age level comparison, negative correlations were found between phase values of M1 and clinical score and duration (p < 0.05, respectively). Similar associations were found in the motor region (p < 0.05, respectively). On both the total (p < 0.01) and elderly (p < 0.05) levels, there were positive relationships between disease progression rate and M1 phase values. In comparing ROC curves, the entire M1 showed the best diagnostic performance. CONCLUSIONS: Combining motor and bulbar analyses as an integral M1 region on SWI can improve ALS diagnosis performance, especially in the elderly. The phase value could be a valuable biomarker for ALS evaluation. KEY POINTS: • Integrated analysis of the motor and bulbar as an entire M1 region on SWI can improve the diagnosis performance in ALS. • Quantitative analysis of iron deposition by SWI measurement helps the clinical evaluation, especially for the elderly patients. • Phase value, when combined with the disease progression rate, could be a valuable biomarker for ALS.
Authors: Michael A van Es; Orla Hardiman; Adriano Chio; Ammar Al-Chalabi; R Jeroen Pasterkamp; Jan H Veldink; Leonard H van den Berg Journal: Lancet Date: 2017-05-25 Impact factor: 79.321
Authors: Matthew C Kiernan; Steve Vucic; Benjamin C Cheah; Martin R Turner; Andrew Eisen; Orla Hardiman; James R Burrell; Margaret C Zoing Journal: Lancet Date: 2011-02-04 Impact factor: 79.321
Authors: H Oba; T Araki; K Ohtomo; S Monzawa; G Uchiyama; K Koizumi; Y Nogata; K Kachi; Z Shiozawa; M Kobayashi Journal: Radiology Date: 1993-12 Impact factor: 11.105
Authors: M Hadzhieva; E Kirches; A Wilisch-Neumann; D Pachow; M Wallesch; P Schoenfeld; I Paege; S Vielhaber; S Petri; G Keilhoff; C Mawrin Journal: Neuroscience Date: 2012-11-20 Impact factor: 3.590
Authors: Justin Y Kwan; Suh Young Jeong; Peter Van Gelderen; Han-Xiang Deng; Martha M Quezado; Laura E Danielian; John A Butman; Lingye Chen; Elham Bayat; James Russell; Teepu Siddique; Jeff H Duyn; Tracey A Rouault; Mary Kay Floeter Journal: PLoS One Date: 2012-04-17 Impact factor: 3.240
Authors: Camille Petillon; Rudolf Hergesheimer; Hervé Puy; Philippe Corcia; Patrick Vourc'h; Christian Andres; Zoubida Karim; Hélène Blasco Journal: Front Neurosci Date: 2019-01-15 Impact factor: 4.677
Authors: Matthew C Kiernan; Steve Vucic; Kevin Talbot; Christopher J McDermott; Orla Hardiman; Jeremy M Shefner; Ammar Al-Chalabi; William Huynh; Merit Cudkowicz; Paul Talman; Leonard H Van den Berg; Thanuja Dharmadasa; Paul Wicks; Claire Reilly; Martin R Turner Journal: Nat Rev Neurol Date: 2020-12-18 Impact factor: 42.937